Search   
MSDS  : 3H-1,4-Benzodiazepine, 7-chloro-2-methylamino-5-phenyl-, 4-oxide, monohydrochloride
CAS  : 438-41-5
SYNONYMS  : * Ansiacal * A-Poxide * Benzodiapin * 3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide, monohydrochloride * Calmoden * Cebrum * Chlordiazachel * Chlordiazepoxide hydrochloride * Chlordiazepoxide monohydrochloride * Contol * Diazachel (Obs.) * Droxol * Equibral * J-Liberty * Labican * Lentotran * Librium hydrochloride * Methaminodiazepoxide hydrochloride * Murcil * Novosed * Psichial * Reliberan * Ro 5-0690 * Seren vita * SK-Lygen * Sophiamin * Tensinyl * Timosin * Trakipeal * Viansin
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : DE9450000
CHEMICAL NAME : 3H-1,4-Benzodiazepine,
7-chloro-2-methylamino-5-phenyl-, 4-oxide,
monohydrochloride
CAS REGISTRY NUMBER : 438-41-5
LAST UPDATED : 199703
DATA ITEMS CITED : 34
MOLECULAR FORMULA : C16-H14-Cl-N3-O.Cl-H
MOLECULAR WEIGHT : 336.24
WISWESSER LINE NOTATION : T67 GN JN IHJ CG HM1 JO KR &GH
COMPOUND DESCRIPTOR : Drug
Mutagen
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* Ansiacal
* A-Poxide
* Benzodiapin
* 3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide,
monohydrochloride
* Calmoden
* Cebrum
* Chlordiazachel
* Chlordiazepoxide hydrochloride
* Chlordiazepoxide monohydrochloride
* Contol
* Diazachel (Obs.)
* Droxol
* Equibral
* J-Liberty
* Labican
* Lentotran
* Librium hydrochloride
* Methaminodiazepoxide hydrochloride
* Murcil
* Novosed
* Psichial
* Reliberan
* Ro 5-0690
* Seren vita
* SK-Lygen
* Sophiamin
* Tensinyl
* Timosin
* Trakipeal
* Viansin

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - man
DOSE/DURATION : 39 mg/kg/30D-I
TOXIC EFFECTS :
Brain and Coverings - changes in surface EEG
Behavioral - hallucinations, distorted perceptions
Behavioral - ataxia
REFERENCE :
CTOXAO Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher
information, see JTCTDW. Volume(issue)/page/year: 2,5,1969

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 8400 ug/kg/2W-I
TOXIC EFFECTS :
Brain and Coverings - changes in surface EEG
Behavioral - somnolence (general depressed activity)
Behavioral - ataxia
REFERENCE :
CTOXAO Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher
information, see JTCTDW. Volume(issue)/page/year: 2,5,1969

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 537 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
16,556,1970

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 276 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
16,556,1970

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZIAQ "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes,
C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973
Volume(issue)/page/year: -,71,1973

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 165 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,159,1972

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 530 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
26RAAN "Benzodinzenines," Garattini, S., et al., New York, Raven Press,
1973 Volume(issue)/page/year: -,39,1973

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc.,
Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC
20037) V.6- 1963- Volume(issue)/page/year: 14,1106,1971

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 530 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,159,1972

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 95 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - muscle weakness
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 129,163,1960

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9,
Washington, DC 20231) Volume(issue)/page/year: #4371536

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZIAQ "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes,
C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973
Volume(issue)/page/year: -,71,1973

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 590 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 178,216,1969

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 36 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - effect, not otherwise specified
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - rigidity (including catalepsy)
REFERENCE :
IJNEAQ International Journal of Neuropharmacology. (New York, NY) V.1-8,
1962-69. For publisher information, see NEPHBW. Volume(issue)/page/year:
5,305,1966

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Bird - quail
DOSE/DURATION : 1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AECTCV Archives of Environmental Contamination and Toxicology.
(Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ
070944) V.1- 1973- Volume(issue)/page/year: 12,355,1983

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2730 mg/kg/13W-C
TOXIC EFFECTS :
Behavioral - food intake (animal)
Nutritional and Gross Metabolic - other changes
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 129,163,1960

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 1365 mg/kg/13W-C
TOXIC EFFECTS :
Behavioral - food intake (animal)
Nutritional and Gross Metabolic - other changes
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 129,163,1960

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 525 mg/kg
SEX/DURATION : female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4
per # born alive)
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85,
Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 17,311,1980

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 1050 mg/kg
SEX/DURATION : female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
Reproductive - Effects on Newborn - stillbirth
Reproductive - Effects on Newborn - live birth index (measured after birth)
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85,
Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 17,311,1980

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 2100 mg/kg
SEX/DURATION : female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85,
Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 17,311,1980

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 48 gm/kg
SEX/DURATION : male 30 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
IJMRAQ Indian Journal of Medical Research. (Indian Council of Medical
Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913-
Volume(issue)/page/year: 66,847,1977

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 28500 ug/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
TOXID9 Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway,
Akron, OH 44311) V.1- 1981- Volume(issue)/page/year: 4,83,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - hamster
DOSE : 28500 ug/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan
R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
Volume(issue)/page/year: 30,39,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Rodent - hamster
DOSE : 280 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
NRTXDN Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR
72203) V.1- 1979- Volume(issue)/page/year: 3,83,1982

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Rodent - hamster
DOSE : 2410 mg/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall
REFERENCE :
NRTXDN Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR
72203) V.1- 1979- Volume(issue)/page/year: 3,83,1982

** MUTATION DATA **

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 1200 mg/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
26,1205,1977

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Bacteria - Escherichia coli
DOSE/DURATION : 1200 mg/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House,
Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year:
26,1205,1977

TYPE OF TEST : Sex chromosome loss and nondisjunction
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Insect - Drosophila melanogaster
DOSE/DURATION : 500 mg/L
REFERENCE :
IJMRAQ Indian Journal of Medical Research. (Indian Council of Medical
Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913-
Volume(issue)/page/year: 76,348,1982

TYPE OF TEST : Micronucleus test
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 188 mg/kg
REFERENCE :
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 18,45,1983

TYPE OF TEST : Micronucleus test
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 67 mg/kg
REFERENCE :
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 18,45,1983

TYPE OF TEST : Dominant lethal test
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 96 gm/kg/30D (Continuous)
REFERENCE :
IJMRAQ Indian Journal of Medical Research. (Indian Council of Medical
Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913-
Volume(issue)/page/year: 66,847,1977

TYPE OF TEST : Host-mediated assay
TEST SYSTEM : Rodent - mouse Bacteria - Salmonella typhimurium
DOSE/DURATION : 188 mg/kg
REFERENCE :
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 16,347,1983

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X5524
No. of Facilities: 56 (estimated)
No. of Industries: 1
No. of Occupations: 3
No. of Employees: 1833 (estimated)
No. of Female Employees: 1102 (estimated)

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Inconclusive: Host-mediated assay


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
1H-1,4-Benzodiazepine-1-carboxamide,2,3-dihydro-N-methyl-7-nitro-2-oxo-5-phenyl- 27016-91-7
1H-1,5-Benzodiazepine-1-carboxamide,2,3,4,5-tetrahydro-2-methyl-4-oxo- 89647-50-7
1H-1,4-Benzodiazepine-3-carboxylic acid,7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassiumsalt, compd. with potassium hydroxide 57109-90-7
1H-1,4-Benzodiazepine-3-carboxylic acid,7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, ethylester 29177-84-2
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-5-(2-chlorophenyl)-1-((methylamino)carbonyl)-2-oxo-, ethyl ester 65400-84-2
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-5-(2-fluorophenyl)-1-((methylamino)carbonyl)-2-oxo-, ethyl ester 65400-85-3
5H-Benzocyclohepten-7-amine, 6,7-dihydro-N-methyl-,hydrochloride, (+)- 62819-45-8
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-2-oxo-5-phenyl-, monopotassiumsalt 5991-71-9
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-chloro-2-oxo-5-phenyl-, phenyl ester 5991-71-9
1H-1,4-Benzodiazepine-3-carboxylic acid,2,3-dihydro-7-nitro-2-oxo-5-phenyl-, monopotassiumsalt 5571-84-6
1H-1,5-Benzodiazepine-2-carboxylic acid,5,5'-(1,2-dioxo-1,2-ethanediyl)bis(2,3,4,5-tetrahydro-2-methyl-4-phenyl-, diethyl ester 144401-02-5
1H-1,4-Benzodiazepine-3-carboxylic acid,2-hydroxy-7-nitro-5-phenyl-, monopotassium salt,compd. with potassium hydroxide 24477-47-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-acetyl-4-methyl-, ethyl ester 121635-52-7
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-acetyl-2-methyl-4- phenyl-,ethyl ester 92911-27-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-benzoyl-4-methyl-, ethyl ester 121635-55-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-benzoyl-2-methyl-4- phenyl-,ethyl ester 92942-83-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((bis(2-methylpropyl)amino)acetyl)-4-methyl-, ethyl ester 121635-59-4
5H-Benzocyclohepten-7-amine,6,7-dihydro-N-methyl-9-phenyl-, hydrochloride 62819-50-5
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-(chloroacetyl)-4-methyl-, ethylester 121635-53-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-(chloroacetyl)-2-methyl-4-phenyl-, ethyl ester 92911-28-9
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-(4-chlorobenzoyl)-4-methyl-,ethyl ester 121635-56-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-5-(4-chlorobenzoyl)-2-methyl-4-phenyl-, ethyl ester 92911-29-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((diethylamino)acetyl)-4-methyl-, ethyl ester 121635-57-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-5-((dipropylamino)acetyl)-4-methyl-, ethyl ester 121635-58-3
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-, ethyl ester 87896-36-4
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(4-morpholinylacetyl)-,ethyl ester 121635-60-7
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(1-oxobutyl)-, ethylester 121635-54-9
1H-1,5-Benzodiazepine-1-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-4-oxo-, ethyl ester 98987-10-1
5H-Benzocyclohepten-7-amine,6,7-dihydro-N-2-propenyl-, hydrochloride 62819-69-6
1H-1,5-Benzodiazepine-5-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-2-oxo-, methyl ester 89647-48-3
1H-1,5-Benzodiazepine-1-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-4-oxo-, phenyl ester 98987-11-2
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-2-methyl-5-(1-oxo-3-phenyl-2-propentyl)-4-phenyl-, ethyl ester 144401-01-4
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-2-methyl-4-phenyl-, ethyl ester 87918-91-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5,-tetrahydro-2-methyl-4-phenyl-5-(1-oxopropyl)-, ethyl ester 92942-82-0
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-methyl-5-(1-piperidinylacetyl)-,ethyl ester 121635-61-8
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl- 87896-33-1
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl-, ethyl ester 87896-35-3
1H-1,5-Benzodiazepine-2-carboxylic acid,2,3,4,5-tetrahydro-4-phenyl-, methyl ester 87896-34-2
3H-1,4-Benzodiazepine,7-chloro-2-(cyclopropylamino)-5-phenyl-, 4-oxide 3864-80-0
5H-Benzocyclohepten-7-amine,6,7,8,9-tetrahydro-5-(4-aminophenoxy)-N,N-dimethyl-,dihydrochloride, cis- 72575-47-4
3H-1,4-Benzodiazepine,7-chloro-2-((cyclopropylmethyl)amino)-5-phenyl-,4-oxide 15687-07-7
1H-1,4-Benzodiazepine,7-chloro-2,3-dihydro-1-methyl-5-phenyl- 2898-12-6
1H-1,4-Benzodiazepine,7-chloro-2,3-dihydro-1-methyl-5-phenyl-,monohydrochloride 2898-11-5
1H-1,4-Benzodiazepine, 7-chloro-2,3-dihydro-5-phenyl 1694-78-6
3H-1,4-Benzodiazepine,7-chloro-2-dimethylamino-5-phenyl-, 4-oxide 3693-14-9
3H-1,4-Benzodiazepine,7-chloro-2-(N-methoxymethyl-N-methylamino)-5-phenyl-,4-oxide 69353-35-1
3H-1,4-Benzodiazepine,7-chloro-2-(methylamino)-5-phenyl-, 4-oxide 58-25-3
3H-1,4-Benzodiazepine,7-chloro-2-(methylamino)-5-phenyl-, 4-oxide andbarbituric acid, 5-ethyl-5-phenyl- (5:3) 63917-56-6
3H-1,4-Benzodiazepine,7-chloro-2-methylamino-5-phenyl-, 4-oxide,monohydrochloride 438-41-5
3H-1,4-Benzodiazepine,7-chloro-2-methylamino-5-phenyl-, 4-oxide, mixed withsodium nitrite (1:1) 104639-49-8

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net